Finland · Delayed Price · Currency is EUR Taaleri Oyj Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw strong earnings growth, driven by Garantia's insurance and renewable energy, with strategic expansion into venture capital and private credit. Biocoal write-downs impacted results, but liquidity and solvency remain robust.
Fiscal Year 2025
-
Continuing earnings rose 17% year-over-year, led by renewable energy and SolarWind III's final close. Garantia expanded its market share, and the first development capital investment was made in Ren-Gas. Outlook for 2026 anticipates stable profitability but lower renewable energy earnings.
-
Q3 revenue and operating profit increased year-over-year, driven by private asset management and fair value gains in investments. Garantia’s market share grew, but weak housing and challenging M&A conditions persist. Strategic focus remains on growth, new strategies, and stable cash flow.
-
The updated strategy for 2026–2028 targets growth in credit risk insurance, private asset management, and development capital, with a focus on scaling flagship funds, expanding into new asset classes, and leveraging synergies. Financial targets include 12% CAGR in operating profit and over 15% return on equity, supported by a strong balance sheet and integrated sustainability.
-
Revenue grew 8.3% to EUR 12.9 million in Q2, with strong private asset management and Garantia investment results. SolarWind III fundraising reached EUR 503 million, and exits from Wind II/III funds are delayed due to slow markets and electricity price volatility.
-
Earnings in private asset management and renewable energy improved, but overall group revenue, operating profit, and EPS declined sharply year-over-year due to market uncertainty and Garantia's weak investment results. Segment reporting was updated for greater transparency.
Fiscal Year 2024
-
Strong 2024 results with growth in income, operating profit, and EPS, supported by successful fundraising and strategic partnerships. Outlook for 2025 is cautious due to market uncertainties, with profitability improvements expected in bioindustry and real estate.
-
Q3 2024 saw strong income growth driven by investment gains, despite a 6% drop in continuing earnings. Fundraising remains slow, with some fund launches postponed and exits potentially delayed to 2025, while cost control and international investor traction support future growth.
-
Continuing earnings grew modestly in Q2 2024, while total income and operating profit declined due to fewer one-time gains. Renewables and bioindustry segments advanced key projects, and Garantia maintained strong profitability. Fundraising and real estate markets remain challenging.